Cart
sales@molnova.com
Yadanzioside G
CAS No. 95258-17-6
Yadanzioside G( —— )
Catalog No. M31503 CAS No. 95258-17-6
Yadanzioside G has antileukemic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 969 | In Stock |
|
| 5MG | 637 | In Stock |
|
| 10MG | 905 | In Stock |
|
| 25MG | 1349 | In Stock |
|
| 50MG | 1786 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYadanzioside G
-
NoteResearch use only, not for human use.
-
Brief DescriptionYadanzioside G has antileukemic activity.
-
DescriptionYadanzioside G has antileukemic activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number95258-17-6
-
Formula Weight768.76
-
Molecular FormulaC36H48O18
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
trans-isrib A17
trans-isrib A17 (ISR-IN-1) is an potent inhibitor of the integrated stress response with EC50 of 0.6 nM.
-
L-Threonine derivati...
L-Threonine derivative-1 is acetylsalicylic acid-L-threonine ester with potential analgesic activity.
-
Laurocapram
Laurocapram is a percutaneous enhancer. Upon application to the skin, laurocapram interacts with lipids in the stratum corneum and may enhance the ability of the skin to absorb a hydrophilic chemical.
